Author:
Turner D. R.,Thomas S. M.
Reference143 articles.
1. Lovett, J.K., A.J. Coull, and P.M. Rothwell, Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology, 2004. 62(4): 569–573.
2. De Schryver, E.L., A. Algra, and J. van Gijn, Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst Rev, 2007. 3: CD001820.
3. van Wijk, I., et al., Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: A cohort study. Lancet, 2005. 365(9477): 2098–2104.
4. Rothwell, P.M. and C.P. Warlow, Timing of TIAs preceding stroke: Time window for prevention is very short. Neurology, 2005. 64(5): 817–820.
5. Hankey, G., Impact of treatment of people with transient ischaemic attack on stroke incidence and public health. Cerebrovasc Dis, 1996. 6(Suppl 1): 26–33.